Caitong International Asset Management’s BioCardia BCDA Stock Holding History

Caitong International Asset Management’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Buy	+1	New	+$1	﹤0.01%	2853

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Caitong International Asset Management's BCDA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in BioCardia (BCDA) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2853 among its holdings.

21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Caitong International Asset Management held 1 share of BioCardia worth $1 as of Q2 2026.
BioCardia was a new Caitong International Asset Management position in Q2 2026.
BioCardia made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2853 holding.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.